Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources
Home/Rare Diseases/Hajdu-Cheney Syndrome

Connective Tissue & Musculoskeletal

Hajdu-Cheney Syndrome Clinical Trials and Treatments

Also called arthro-dento-osteodysplasia, acro-osteolysis, NOTCH2 mutation

Hajdu-Cheney syndrome (HCS) is a rare autosomal dominant skeletal dysplasia caused by truncating variants in the last exon of the NOTCH2 gene, which leave the NOTCH2 signaling protein overactive; many cases arise from a new variant rather than being inherited. The condition is characterized by progressive acroosteolysis (loss of terminal phalanges, particularly affecting fingers and toes), which begins in childhood and progressively worsens through adolescence and adulthood, eventually leading to significant digital shortening.

In plain words, Hajdu-Cheney syndrome is a rare genetic bone condition where the tips of the finger and toe bones slowly wear away. Many people also develop painful joint problems, dental issues, and weaker bones that affect hand use and daily tasks.

Get an email when new Hajdu-Cheney Syndrome trials open or the FDA decides. Get alerts

Hajdu-Cheney Syndrome

Where treatments stand, from ClinicalTrials.gov and FDA labels

FDA review0

No decision pending. FDA calendar

FDA-approved medicines0

No medicine's current FDA label names Hajdu-Cheney Syndrome yet.

Hajdu-Cheney Syndrome has no FDA-approved medicines, 0 open or active clinical trials (0 recruiting), and no pending FDA decision.

Labels checked October 21, 2026.Download the data

More about Hajdu-Cheney Syndrome

Affected individuals develop severe arthritis affecting multiple joints including knees, hips, shoulders, and spine, causing progressive pain and functional limitation. Many people have short stature, and distinctive features include delayed tooth eruption, dental abnormalities including peg-shaped teeth, and characteristic craniofacial changes with frontal bossing and midface hypoplasia. Bone density abnormalities including osteopenia or osteoporosis develop, compounding fracture risk.

Keep reading about Hajdu-Cheney Syndrome

Progressive loss of digital bone material leads to shortened fingers and severely limited hand function for fine motor tasks. Hearing loss occurs in some patients due to ossicular involvement. Cardiac abnormalities are rare but reported. Spinal involvement including kyphosis and vertebral abnormalities develops. Progressive joint destruction and digit loss significantly impact functional ability, quality of life, and psychological well-being, particularly regarding hand dexterity and social functioning.

What are the symptoms of Hajdu-Cheney Syndrome?

These are common symptoms of Hajdu-Cheney Syndrome, and how strong they are varies from person to person.

  • Acroosteolysis and shortening of fingers and toes
  • Progressive arthritis and joint destruction
  • Dental abnormalities and delayed eruption
  • Distinctive facial features
  • Bone abnormalities on imaging
  • Limited hand function

Who gets Hajdu-Cheney Syndrome?

Manifestations begin in infancy and progress through childhood and adulthood with progressive worsening of acroosteolysis and arthritis. Affects males and females equally with no gender predominance. Autosomal dominant inheritance with high penetrance and variable expressivity; many cases represent new variants without family history.

Many cases come from a new (de novo) variant with no family history, according to MedlinePlus, and a parent with the condition has a 50% chance of passing the variant to each child, according to NORD. No ethnic or racial predisposition documented. Diagnosis often delayed due to rarity; fingertip bone loss is usually not present at birth and becomes apparent in childhood or later.

Next steps: find trials you might fitsee what is being testedget help payingget alerts

Side effects people have reported to the FDA

Side effects people have reported to the FDA

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Diagnosis and genetic testing

Genetic testing for Hajdu-Cheney Syndrome

Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.

Finding labs...

Trusted Hajdu-Cheney Syndrome resources

Reputable organizations and medical references for learning more about Hajdu-Cheney Syndrome, including disease registries, foundation resources, and clinical guidelines.

Active clinical trials for Hajdu-Cheney Syndrome

This Hajdu-Cheney Syndrome clinical trial finder lists studies as they become available, with eligibility criteria in plain English. Every trial comes from ClinicalTrials.gov.

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

No active clinical trials yet

Hajdu-Cheney Syndrome is a classified rare disease, but clinical trial activity for it is limited. That's part of why we track it. When a trial opens, Trial Friend will have it.

Get an email the moment a Hajdu-Cheney Syndrome trial is registered on ClinicalTrials.gov.

Hajdu-Cheney Syndrome patient communities

Facebook groups, Reddit communities and YouTube channels where Hajdu-Cheney Syndrome patients, caregivers and advocacy groups talk.

Questions people ask about Hajdu-Cheney Syndrome